vs

Side-by-side financial comparison of Custom Truck One Source, Inc. (CTOS) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.

Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $422.2M, roughly 1.5× Custom Truck One Source, Inc.). Royalty Pharma plc runs the higher net margin — 34.4% vs -4.2%, a 38.7% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs -8.5%). Over the past eight quarters, Custom Truck One Source, Inc.'s revenue compounded faster (14.8% CAGR vs 4.6%).

Custom Truck One Source, Inc. is a leading provider of specialized heavy truck and equipment solutions in North America. It offers custom vehicle manufacturing, equipment sales and rentals, aftermarket parts, and maintenance services, serving core infrastructure, utility, construction, and energy industry segments.

Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.

CTOS vs RPRX — Head-to-Head

Bigger by revenue
RPRX
RPRX
1.5× larger
RPRX
$622.0M
$422.2M
CTOS
Growing faster (revenue YoY)
RPRX
RPRX
+13.3% gap
RPRX
4.8%
-8.5%
CTOS
Higher net margin
RPRX
RPRX
38.7% more per $
RPRX
34.4%
-4.2%
CTOS
Faster 2-yr revenue CAGR
CTOS
CTOS
Annualised
CTOS
14.8%
4.6%
RPRX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CTOS
CTOS
RPRX
RPRX
Revenue
$422.2M
$622.0M
Net Profit
$-17.8M
$214.2M
Gross Margin
20.3%
Operating Margin
2.9%
62.4%
Net Margin
-4.2%
34.4%
Revenue YoY
-8.5%
4.8%
Net Profit YoY
-333.7%
2.9%
EPS (diluted)
$-0.08
$0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTOS
CTOS
RPRX
RPRX
Q1 26
$422.2M
Q4 25
$387.3M
$622.0M
Q3 25
$359.9M
$609.3M
Q2 25
$392.2M
$578.7M
Q1 25
$307.1M
$568.2M
Q4 24
$398.3M
$593.6M
Q3 24
$337.5M
$564.7M
Q2 24
$320.6M
$537.3M
Net Profit
CTOS
CTOS
RPRX
RPRX
Q1 26
$-17.8M
Q4 25
$20.9M
$214.2M
Q3 25
$-5.8M
$288.2M
Q2 25
$-28.4M
$30.2M
Q1 25
$-17.8M
$238.3M
Q4 24
$27.6M
$208.2M
Q3 24
$-17.4M
$544.0M
Q2 24
$-24.5M
$102.0M
Gross Margin
CTOS
CTOS
RPRX
RPRX
Q1 26
20.3%
Q4 25
31.8%
Q3 25
28.0%
Q2 25
26.1%
Q1 25
27.9%
Q4 24
29.7%
Q3 24
27.2%
Q2 24
27.8%
Operating Margin
CTOS
CTOS
RPRX
RPRX
Q1 26
2.9%
Q4 25
13.4%
62.4%
Q3 25
9.1%
70.1%
Q2 25
7.1%
36.3%
Q1 25
4.0%
94.0%
Q4 24
16.9%
60.9%
Q3 24
6.8%
Q2 24
5.5%
50.2%
Net Margin
CTOS
CTOS
RPRX
RPRX
Q1 26
-4.2%
Q4 25
5.4%
34.4%
Q3 25
-1.6%
47.3%
Q2 25
-7.2%
5.2%
Q1 25
-5.8%
41.9%
Q4 24
6.9%
35.1%
Q3 24
-5.2%
96.3%
Q2 24
-7.6%
19.0%
EPS (diluted)
CTOS
CTOS
RPRX
RPRX
Q1 26
$-0.08
Q4 25
$0.10
$0.49
Q3 25
$-0.03
$0.67
Q2 25
$-0.13
$0.07
Q1 25
$-0.08
$0.55
Q4 24
$0.11
$0.46
Q3 24
$-0.07
$1.21
Q2 24
$-0.10
$0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTOS
CTOS
RPRX
RPRX
Cash + ST InvestmentsLiquidity on hand
$6.3M
$618.7M
Total DebtLower is stronger
$25.9M
$9.0B
Stockholders' EquityBook value
$809.1M
$9.7B
Total Assets
$3.4B
$19.6B
Debt / EquityLower = less leverage
0.03×
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTOS
CTOS
RPRX
RPRX
Q1 26
$6.3M
Q4 25
$6.3M
$618.7M
Q3 25
$13.1M
$938.9M
Q2 25
$5.3M
$631.9M
Q1 25
$5.4M
$1.1B
Q4 24
$3.8M
$929.0M
Q3 24
$8.4M
$950.1M
Q2 24
$8.1M
$1.8B
Total Debt
CTOS
CTOS
RPRX
RPRX
Q1 26
$25.9M
Q4 25
$1.6B
$9.0B
Q3 25
$1.6B
$8.9B
Q2 25
$1.6B
$8.0B
Q1 25
$1.6B
$7.6B
Q4 24
$1.5B
$7.6B
Q3 24
$1.6B
$7.6B
Q2 24
$1.5B
$7.6B
Stockholders' Equity
CTOS
CTOS
RPRX
RPRX
Q1 26
$809.1M
Q4 25
$809.1M
$9.7B
Q3 25
$784.7M
$9.6B
Q2 25
$790.1M
$9.5B
Q1 25
$813.4M
$9.8B
Q4 24
$861.3M
$10.3B
Q3 24
$837.5M
$10.3B
Q2 24
$856.7M
$9.8B
Total Assets
CTOS
CTOS
RPRX
RPRX
Q1 26
$3.4B
Q4 25
$3.4B
$19.6B
Q3 25
$3.5B
$19.3B
Q2 25
$3.6B
$18.3B
Q1 25
$3.5B
$17.6B
Q4 24
$3.5B
$18.2B
Q3 24
$3.6B
$18.0B
Q2 24
$3.5B
$17.7B
Debt / Equity
CTOS
CTOS
RPRX
RPRX
Q1 26
0.03×
Q4 25
2.03×
0.92×
Q3 25
2.10×
0.93×
Q2 25
2.04×
0.84×
Q1 25
1.97×
0.78×
Q4 24
1.77×
0.74×
Q3 24
1.87×
0.74×
Q2 24
1.79×
0.78×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTOS
CTOS
RPRX
RPRX
Operating Cash FlowLast quarter
$827.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.86×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTOS
CTOS
RPRX
RPRX
Q1 26
Q4 25
$47.3M
$827.1M
Q3 25
$81.5M
$702.6M
Q2 25
$125.7M
$364.0M
Q1 25
$55.6M
$596.1M
Q4 24
$82.1M
$742.5M
Q3 24
$16.5M
$703.6M
Q2 24
$37.8M
$658.2M
Cash Conversion
CTOS
CTOS
RPRX
RPRX
Q1 26
Q4 25
2.27×
3.86×
Q3 25
2.44×
Q2 25
12.06×
Q1 25
2.50×
Q4 24
2.98×
3.57×
Q3 24
1.29×
Q2 24
6.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTOS
CTOS

Equipment sales$273.9M65%
Rental revenue$116.3M28%
Parts sales and services$32.1M8%

RPRX
RPRX

Financial Royalty Assets$592.4M95%
Royalty Income Other$29.6M5%

Related Comparisons